Icon	Function
💬	A pop-up explanation appears when you mouse-over the text beside this icon. Also, an explanation window appears when you click this icon.
	The links beside this icon are links to external sites.
	Clicking this icon sorts the table by the item with this icon (Numerical or alphabetical order). Each click toggles between ascending and descending order.
	A text longer than 100 characters is fully displayed or collapsed.
	The contents of the displayed table are downloaded as a file named "table.csv".

KEGG DRUG

Search results

No.

Drug (Description in trials)

DrugBank

KEGG DRUG

KEGG GENES

KEGG PATHWAY

Disease ID

ALEMTUZUMAB

[1] Alemtuzumab (Alemtuzumab)

[1] Alemtuzumab (Alemtuzumab) 💬

[21] 13, 14, 15, 19, 20, 36, 43, 44, 46, 51, 60, 63, 65, 85, 96, 107, 164, 283, 284, 285, 326 💬

Disease ID	Name
13	Multiple sclerosis/Neuromyelitis optica
14	Chronic inflammatory demyelinating polyneuropathy
15	Inclusion body myositis
19	Lysosomal storage disease
20	Adrenoleukodystrophy
36	Epidermolysis bullosa
43	Microscopic polyangiitis
44	Wegener granulomatosis
46	Malignant rheumatoid arthritis
51	Scleroderma
60	Aplastic anemia
63	Idiopathic thrombocytopenic purpura
65	Primary immunodeficiency
85	Idiopathic interstitial pneumonia
96	Crohn disease
107	Juvenile idiopathic arthritis
164	Oculocutaneous albinism
283	Acquired pure red cell aplasia
284	Diamond-Blackfan anemia
285	Fanconi anemia
326	Osteopetrosis

Alemtuzumab (already received by alemtuzumab cohort between 1991 and 1994

[1] Alemtuzumab (Alemtuzumab)

[1] Alemtuzumab (Alemtuzumab) 💬

[1] 46 💬

Alemtuzumab (already received by alemtuzumab cohort between 1991 and 1994)

[1] Alemtuzumab (Alemtuzumab)

[1] Alemtuzumab (Alemtuzumab) 💬

[1] 46 💬

Alemtuzumab (Campath )

[1] Alemtuzumab (Alemtuzumab)

[1] Alemtuzumab (Alemtuzumab) 💬

[1] 60 💬

Alemtuzumab (Campath)

[1] Alemtuzumab (Alemtuzumab)

[1] Alemtuzumab (Alemtuzumab) 💬

[1] 15 💬

Alemtuzumab (GZ402673)

[1] Alemtuzumab (Alemtuzumab)

[1] Alemtuzumab (Alemtuzumab) 💬

[1] 13 💬

Alemtuzumab 0.2 mg

[1] Alemtuzumab (Alemtuzumab)

[1] Alemtuzumab (Alemtuzumab) 💬

[2] 65, 164 💬

Alemtuzumab 0.3 mg

[1] Alemtuzumab (Alemtuzumab)

[1] Alemtuzumab (Alemtuzumab) 💬

[2] 65, 164 💬

Alemtuzumab 12 mg

[1] Alemtuzumab (Alemtuzumab)

[1] Alemtuzumab (Alemtuzumab) 💬

[1] 13 💬

Alemtuzumab 24 mg

[1] Alemtuzumab (Alemtuzumab)

[1] Alemtuzumab (Alemtuzumab) 💬

[1] 13 💬

Alemtuzumab and Rituximab

[2] Alemtuzumab (Alemtuzumab),
Rituximab

[2] Alemtuzumab (Alemtuzumab),
Rituximab 💬

[1] MS4A1 💬

[1] Hematopoietic cell lineage 💬

[1] 60 💬

Alemtuzumab GZ402673

[1] Alemtuzumab (Alemtuzumab)

[1] Alemtuzumab (Alemtuzumab) 💬

[1] 13 💬

Alemtuzumab immunotherapy

[1] Alemtuzumab (Alemtuzumab)

[1] Alemtuzumab (Alemtuzumab) 💬

[1] 13 💬

Alemtuzumab infusion

[1] Alemtuzumab (Alemtuzumab)

[1] Alemtuzumab (Alemtuzumab) 💬

[1] 14 💬

Alemtuzumab Injection

[1] Alemtuzumab (Alemtuzumab)

[1] Alemtuzumab (Alemtuzumab) 💬

[1] 13 💬

Alemtuzumab Injection [Lemtrada]

[1] Alemtuzumab (Alemtuzumab)

[1] Alemtuzumab (Alemtuzumab) 💬

[1] 13 💬

Alemtuzumab, Rituximab

[2] Alemtuzumab (Alemtuzumab),
Rituximab

[2] Alemtuzumab (Alemtuzumab),
Rituximab 💬

[1] MS4A1 💬

[1] Hematopoietic cell lineage 💬

[1] 63 💬

CAMPATH-1H (Alemtuzumab)

[1] Alemtuzumab (Alemtuzumab)

[1] Alemtuzumab (Alemtuzumab) 💬

[1] 60 💬

Interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab

[12] Acetate,
Alemtuzumab (Alemtuzumab),
Cladribine,
Dimethyl fumarate,
Fingolimod,
Glatiramer,
Natalizumab,
Ocrelizumab,
Ofatumumab,
Ponesimod,
Rituximab,
Teriflunomide

[13] Cladribine ,
Alemtuzumab (Alemtuzumab),
Rituximab ,
Dimethyl fumarate ,
Fingolimod hydrochloride ,
Glatiramer acetate ,
Ocrelizumab ,
Natalizumab ,
Ofatumumab ,
Fingolimod ,
Teriflunomide ,
Ponesimod ,
Fingolimod lauryl sulfate 💬

Name	Other Names
Cladribine	Leustatin Mavenclad
Alemtuzumab	Campath Lemtrada
Rituximab	Rituximab-abbs Rituximab-pvvr Rituximab-arrx Rituxan Riabni Truximab RUXIENCE TRUXIMA
Dimethyl fumarate	Tecfidera
Fingolimod hydrochloride	Gilenya FINGOLIMOD
Glatiramer acetate	Copaxone GLATOPA
Ocrelizumab	Ocrevus OCREVUS ZUNOVO
Natalizumab	Natalizumab-sztn Tysabri Tyruko
Ofatumumab	Arzerra Kesimpta
Fingolimod	Gilenya
Teriflunomide	Aubagio
Ponesimod	Ponvory
Fingolimod lauryl sulfate	Tascenso TASCENSO ODT

[26] DHODH,
HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G,
ITGA4,
KEAP1,
MS4A1,
RRM1,
S1PR1 💬

Name	Full Name
DHODH	dihydroorotate dehydrogenase (quinone), mitochondrial
HLA-A	HLA class I histocompatibility antigen, A alpha chain isoform A*03:01:01:01 precursor
HLA-B	major histocompatibility complex, class I, B precursor
HLA-C	HLA class I histocompatibility antigen, C alpha chain precursor
HLA-DMA	HLA class II histocompatibility antigen, DM alpha chain precursor
HLA-DMB	HLA class II histocompatibility antigen, DM beta chain precursor
HLA-DOA	HLA class II histocompatibility antigen, DO alpha chain precursor
HLA-DOB	HLA class II histocompatibility antigen, DO beta chain precursor
HLA-DPA1	HLA class II histocompatibility antigen, DP alpha 1 chain precursor
HLA-DPB1	HLA class II histocompatibility antigen, DP beta 1 chain precursor
HLA-DQA1	HLA class II histocompatibility antigen, DQ alpha 1 chain precursor
HLA-DQA2	HLA class II histocompatibility antigen, DQ alpha 2 chain precursor
HLA-DQB1	HLA class II histocompatibility antigen, DQ beta 1 chain isoform 2 precursor
HLA-DRA	HLA class II histocompatibility antigen, DR alpha chain precursor
HLA-DRB1	major histocompatibility complex, class II, DR beta 1 precursor
HLA-DRB3	major histocompatibility complex, class II, DR beta 3 precursor
HLA-DRB4	major histocompatibility complex, class II, DR beta 4 precursor
HLA-DRB5	major histocompatibility complex, class II, DR beta 5 precursor
HLA-E	HLA class I histocompatibility antigen, alpha chain E precursor
HLA-F	HLA class I histocompatibility antigen, alpha chain F isoform 2 precursor
HLA-G	HLA class I histocompatibility antigen, alpha chain G isoform 2 precursor
ITGA4	integrin alpha-4 isoform 1 preproprotein
KEAP1	kelch-like ECH-associated protein 1
MS4A1	B-lymphocyte antigen CD20
RRM1	ribonucleoside-diphosphate reductase large subunit isoform 1
S1PR1	sphingosine 1-phosphate receptor 1

[58] Allograft rejection, Antigen processing and presentation, Arrhythmogenic right ventricular cardiomyopathy, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Chemical carcinogenesis - reactive oxygen species, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Drug metabolism - other enzymes, ECM-receptor interaction, Efferocytosis, Endocytosis, Epstein-Barr virus infection, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Glutathione metabolism, Graft-versus-host disease, Hematopoietic cell lineage, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Inflammatory bowel disease, Influenza A, Integrin signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Leukocyte transendothelial migration, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Pathways in cancer, Phagocytosis, Purine metabolism, Pyrimidine metabolism, Regulation of actin cytoskeleton, Rheumatoid arthritis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Ubiquitin mediated proteolysis, Viral carcinogenesis, Viral myocarditis, Yersinia infection 💬

[1] 13 💬

Other: Natalizumab/natalizumab-sztn, Alemtuzumab, Ocrelizumab, Rituximab/rituximab-arrx/rituximab-abbs/rituximab-pvvr, Cladribine, Ofatumumab, Ublituximab-xiiy, Ocrelizumab and hyaluronidase-ocsq

[8] Alemtuzumab (Alemtuzumab),
Cladribine,
Hyaluronidase,
Natalizumab,
Ocrelizumab,
Ofatumumab,
Rituximab,
Ublituximab

[10] Cladribine ,
Alemtuzumab (Alemtuzumab),
Rituximab ,
Hyaluronidase ,
Hyaluronidase ,
Ocrelizumab ,
Hyaluronidase ,
Natalizumab ,
Ofatumumab ,
Ublituximab 💬

Name	Other Names
Cladribine	Leustatin Mavenclad
Alemtuzumab	Campath Lemtrada
Rituximab	Rituximab-abbs Rituximab-pvvr Rituximab-arrx Rituxan Riabni Truximab RUXIENCE TRUXIMA
Hyaluronidase	HYO 6A Vitrase
Hyaluronidase	Amphadase
Ocrelizumab	Ocrevus OCREVUS ZUNOVO
Hyaluronidase	Vorhyaluronidase alfa Hylenex recombinant
Natalizumab	Natalizumab-sztn Tysabri Tyruko
Ofatumumab	Arzerra Kesimpta
Ublituximab	Briumvi

[3] ITGA4,
MS4A1,
RRM1 💬

[21] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Drug metabolism - other enzymes, ECM-receptor interaction, Focal adhesion, Glutathione metabolism, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Purine metabolism, Pyrimidine metabolism, Regulation of actin cytoskeleton, Yersinia infection 💬

[1] 13 💬

Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan

[4] Alemtuzumab (Alemtuzumab),
Fludarabine,
Melphalan,
Thiotepa

[6] Melphalan ,
Thiotepa ,
Fludarabine phosphate ,
Alemtuzumab (Alemtuzumab),
Fludarabine ,
Melphalan hydrochloride 💬

Name	Other Names
Melphalan	Alkeran
Thiotepa	Thioplex Tepadina Rethio TEPYLUTE
Fludarabine phosphate	Fludara
Alemtuzumab	Campath Lemtrada
Fludarabine	Fluradosa
Melphalan hydrochloride	Alkeran Evomela HEPZATO KIT IVRA MELPHALAN

[1] RRM1 💬

[4] Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬

[2] 65, 164 💬